SE8603135L - N NIKOTINOYLAMINOSYROR - Google Patents

N NIKOTINOYLAMINOSYROR

Info

Publication number
SE8603135L
SE8603135L SE8603135A SE8603135A SE8603135L SE 8603135 L SE8603135 L SE 8603135L SE 8603135 A SE8603135 A SE 8603135A SE 8603135 A SE8603135 A SE 8603135A SE 8603135 L SE8603135 L SE 8603135L
Authority
SE
Sweden
Prior art keywords
image
compounds
disorders
3cooh
nicotinoylamino
Prior art date
Application number
SE8603135A
Other languages
Swedish (sv)
Other versions
SE455093B (en
SE8603135D0 (en
Inventor
L D Smirnov
T A Voronina
L G Stolyarova
T L Garibova
R A Akhundov
E A Kuznetsova
K M Djumaev
A V Valdman
G M Rudenko
Original Assignee
Nii Farmakol Akad Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nii Farmakol Akad Med filed Critical Nii Farmakol Akad Med
Priority to SE8603135A priority Critical patent/SE455093B/en
Publication of SE8603135D0 publication Critical patent/SE8603135D0/en
Priority to CH2923/86A priority patent/CH667648A5/en
Priority to BE0/216961A priority patent/BE905154A/en
Priority to FR8611224A priority patent/FR2602232B1/en
Priority to JP61186714A priority patent/JPS6344565A/en
Publication of SE8603135L publication Critical patent/SE8603135L/en
Publication of SE455093B publication Critical patent/SE455093B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

The present invention relates to organic chemistry. The new compounds: N-Nicotinoylamino acids have the following general formula: <IMAGE> where for R' = <IMAGE> R'' = OH, Br; for R' = <IMAGE> , R'' = OH for R' = NH(CH2)3COOH, R'' = OH. The claimed compounds have an antihypoxic and antiamnesic activity and may have their application in medicine as agents of the type having nootropic action for the treatment of pathological states, especially of memory disorders, of cerebral circulation disorders, of after-effects of craniocerebral traumas and in geriatric practice.
SE8603135A 1986-07-16 1986-07-16 N NIKOTINOYLAMINOSYROR SE455093B (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8603135A SE455093B (en) 1986-07-16 1986-07-16 N NIKOTINOYLAMINOSYROR
CH2923/86A CH667648A5 (en) 1986-07-16 1986-07-22 N-nikotinoylaminosaeuren.
BE0/216961A BE905154A (en) 1986-07-16 1986-07-23 N-NICOTINOYLAMINE ACIDS.
FR8611224A FR2602232B1 (en) 1986-07-16 1986-08-01 N-NICOTINOYLAMINE ACIDS
JP61186714A JPS6344565A (en) 1986-07-16 1986-08-08 N-nicotinoylamino acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8603135A SE455093B (en) 1986-07-16 1986-07-16 N NIKOTINOYLAMINOSYROR

Publications (3)

Publication Number Publication Date
SE8603135D0 SE8603135D0 (en) 1986-07-16
SE8603135L true SE8603135L (en) 1988-01-17
SE455093B SE455093B (en) 1988-06-20

Family

ID=20365125

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603135A SE455093B (en) 1986-07-16 1986-07-16 N NIKOTINOYLAMINOSYROR

Country Status (5)

Country Link
JP (1) JPS6344565A (en)
BE (1) BE905154A (en)
CH (1) CH667648A5 (en)
FR (1) FR2602232B1 (en)
SE (1) SE455093B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06113106A (en) * 1992-09-25 1994-04-22 Ricoh Co Ltd Data reading processor
US6420427B1 (en) * 1997-10-09 2002-07-16 Ono Pharmaceutical Co., Ltd. Aminobutyric acid derivatives
JP6479522B2 (en) 2015-03-23 2019-03-06 本田技研工業株式会社 Cable connection mechanism
RU2612253C1 (en) * 2016-03-23 2017-03-03 Общество с ограниченной ответственностью "ТАВИТА" Method for producing n-(5-hydroxynicotinoyl)-l-glutamic acid

Also Published As

Publication number Publication date
CH667648A5 (en) 1988-10-31
BE905154A (en) 1987-01-23
SE455093B (en) 1988-06-20
JPS6344565A (en) 1988-02-25
FR2602232B1 (en) 1988-11-10
FR2602232A1 (en) 1988-02-05
SE8603135D0 (en) 1986-07-16

Similar Documents

Publication Publication Date Title
ATE411026T1 (en) AGENTS FOR THE TREATMENT OF ALZHEIMER&#39;S DISEASE
ATE185345T1 (en) 1,4-DISUBSTITUTED PIPERAZINE FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND NERVOUS ENDOCRINE DISEASES
DE3370626D1 (en) Imidazolylalkylthienyl-tetrahydropyridazines and process for their preparation
DE3581699D1 (en) BIS-DIMETHOXYMETHYL (TRIMETHOXYBENZYL) ISOCHINOLINIUM SALTS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FI961809A (en) Novel (R) -5-carbamoyl-8-fluoro-3-N, N-disubstituted amino 3,4-dihydro-2H-1-benzopyrans
ES549776A0 (en) PROCEDURE FOR THE PREPARATION OF PYRROLLO-BENCIMIDAZOLES
RU94038256A (en) Derivatives of pyrazolopyrimidine, method of their synthesis, pharmaceutical compositions based on thereof
NO161972C (en) ANALOGY PROCEDURE MEASURES FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-SUBSTITUTED TETRALIN DERIVATIVES.
PT75460A (en) 2-&lt;2&#39;-hydroxy-3&#39;-(1,1-dimethylpropylamino)-propoxy&gt;-beta-phenylpropiophenone its acid addition salts process for its preparation and pharmaceutical compositions
SE8603135L (en) N NIKOTINOYLAMINOSYROR
ATE157660T1 (en) HYDROXYMETHYLFURAZANECARBOXYLIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES
NO892152D0 (en) CONDENSED DIAZE PINONES, MANUFACTURING THEREOF AND PHARMACEUTICALS CONTAINING THEM.
DE68900516D1 (en) THERAPEUTIC AGENTS FOR TREATING STOMACH.
ATE75399T1 (en) THERAPEUTIC FOR TREATMENT OF STOMACH ULCERS.
HUT57749A (en) Process for producing pharmaceutical compositions suitable for treating pathological conditions concerning cerebral blood insufficiency and one special active ingredient
FI853229L (en) NYA BENZODIAZEPINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING.
DE3476520D1 (en) Use of a mixture of compounds for the manufacture of a composition for the treatment of buerger&#39;s disease
ATE27272T1 (en) 1-AROYL-5-OXO-2-PYRROLIDINEPROPANOIC ACID AND ESTERS THEREOF.
ATE82016T1 (en) 1,4-DIHYDROPYRIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS.
RU93036929A (en) METHOD OF CLEANING GADOLINIA-153 PREPARATION FROM EUROPY-152
DE59107405D1 (en) An imidazobenzodiazepine used to treat sleep disorders
RU97111543A (en) METHOD FOR TREATING NEUROLOGICAL DISORDERS RELATED TO THE CHRONIC FORM OF CONGENITAL VIRAL INFECTION
RU93058599A (en) NEW DIMETHYLAMINE-OXYALCANDIPHOSPHONIC ACIDS AND THEIR SALTS, METHOD FOR PRODUCING THERE CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS, APPLICATION

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8603135-8

Effective date: 19950210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8603135-8

Format of ref document f/p: F